Toray and 3SBio enter license agreement for orally disintegrating formulation of TRK-820 in China Jan. 15, 2018
AbbVie's upadacitinib awarded FDA breakthrough therapy designation for atopic dermatitis Jan. 9, 2018
Asana BioSciences' ASN-002 shows efficacy in atopic dermatitis in proof-of-concept study Jan. 5, 2018
RSS